Navigation Links
Anti-smoking TV ads should use anger, Dartmouth-Cornell study suggests
Date:4/29/2014

Anti-smoking television advertisements that appeal to viewers' emotions are more persuasive when they use anger rather than sadness, a Dartmouth-Cornell study suggests.

The study appears in the Journal of Health Communication. A PDF is available on request.

Previous studies have shown emotional expression is a crucial part of persuasion, and that audience members' perceptions of emotions affect their attitudes and behaviors. Previous research also has shown anti-smoking TV ads that convey negative emotions such as anger and sadness are more effective than non-emotional approaches.

In the new study, researchers from Dartmouth College's Geisel School of Medicine and Cornell University examined how viewers process those negative emotions. They produced anti-smoking TV ads in which an actor delivered anti-smoking messages to 115 college students with either anger or sadness by using different vocal tones and facial expressions. To measure the role of emotions in the ads, the researchers manipulated the actor's expressed emotions while keeping the story the same.

Results showed the anger-framed ad was more effective because it increased the perceived dominance of the speaker, which increased anti-smoking attitudes and predicted strong intentions not to smoke. The findings also showed participants who watched the anger-framed message didn't find the actor likable or empathetic, but those factors were not associated with intention to quit smoking.


'/>"/>

Contact: John Cramer
John.Cramer@Dartmouth.edu
603-646-9130
Dartmouth College
Source:Eurekalert

Page: 1

Related medicine news :

1. Small neural focus groups predict anti-smoking ad success
2. Anti-Smoking Ads Have Increased Quit Attempts: CDC
3. Anti-Smoking Progress Stalls Among U.S. Adults: Report
4. Genes May Influence Effectiveness of Anti-Smoking Policies
5. Anti-smoking ads with strong arguments, not flashy editing, trigger part of brain involving behavior change
6. Online comments can undermine anti-smoking PSAs
7. Canada should play a role in addressing the global cancer epidemic
8. New standards for treating traumatic shoulder injuries to improve patient care
9. Should oxygen be used for patients with chronic heart failure?
10. Men Can Still Ask for PSA Test, and Some Should, Doctors Say
11. Canada should significantly increase its funding of randomized clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... If you don’t mind a bit of prickly ... may want to consider a treatment that some have called the next great tool ... , Microneedling, also known as skin needling, is a procedure using a device covered ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Medical Society of Northern Virginia, Announces DoctorsTelemed?, A telehealth solution powered ... of Northern Virginia (MSNVA) launches DoctorsTelemed?, a telemedicine solution that uses CloudVisit’s ...
(Date:5/5/2016)... ... May 05, 2016 , ... Augusta Public Schools has teamed with ... partnership will enable school health offices to streamline and bolster care for district students. ... east of Wichita. Augusta public schools serve 2,300 students among its six schools. ...
(Date:5/5/2016)... ... 2016 , ... The Wisconsin Independent Private Practice Alliance (WIPPA/aka ... WCS, has been selected by the Wisconsin Physical Therapy Association (WPTA) as this ... is awarded annually to a member of the WPTA to recognize a Wisconsin ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... patented products, announces the Everlasting Glove, a sports invention that aids in the ... Sporting Goods Manufacturing industry is worth $9 billion," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016  It,s time for an upgrade. There are many ... a brilliant 3.5 inch LCD, the illustrious DVMAXX HD  offers unparalleled connectivity and ... well as a world class manufacturer of innovative technology.  Photo - ... ... ...
(Date:5/4/2016)... , May 4, 2016 ... of Jerusalem announced today that it had signed ... BioTheryX, Inc. , developer of novel protein degradation and ... development and commercialization of drug candidates representing first-in-class therapy ... license were not disclosed. The novel technology ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Multiple Myeloma ...  report to their offering.       ... Multiple Myeloma Market and Competitive Landscape Highlights ... pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma ...
Breaking Medicine Technology: